Cholecystokinin 33 (CCK) was infused intravenously to eight healthy obese wom en and 10 healthy lean women o f the same age, in doses that elicited plasm a cholecystokinin concentrations in the physiological range. The effect o f these infusions after a standardised banana 'shake5 (preload) on food intake and satiety signals was com pared with the effect o f saline infusions in the sam e subjects. For the whole group food intake (m ean (SEM)) (282 (29 g)) was signifi cantly less during CCK than during saline (346 (31) g, p<0*05). Hunger feelings tended to be less during CCK infusions.
Many studies have shown that cholecystokinin (CCK) reduces food intake in several species including humans.l~14 In these studies, how ever, CCK plasma concentrations were not measured and the reported feeding depression may well have been caused by supraphysiological doses of CCK. Wolkowitz on the other hand reported that CCK receptor blockade increased hunger in humans showing that CCK may have a physiological satiety effect also in humans. 15 It has recently been shown that an infusion of CCK 33 leading to high physiological plasma concentrations does not have an important effect on food intake and postprandial satiation in humans in a study where no preload was given.16 A gastric load, however,, potentiates the inhibition of food intake produced by cholecystokinin and reduces the threshold dose of a CCK analogue required to inhibit food intake in monkeys and rats.1217 In the human studies of Pi-Suyner and Kissileff where a CCK 8 infusion dimin ished food intake in lean and obese humans, an appetiser* consisting of crackers and jelly (216 kcal) was given 12 minutes before the start of the liquid meal.3 4 Muurahainen ei al reported that a 500 g but not 100 g soup pre load combined with CCK 8 225 ng/ml/min significantly decreased food intake in nonobese humans compared with the same pre load with a saline infusion. 18 We therefore studied the effects of intravenous infusion of CCK 33, in a dose that leads to high physio logical plasma concentrations, on food intake, 15 minutes after a preload, and satiety signals in lean and obese volunteers. Apart from the preload this study design is comparable with our previous investigation, 16 We infused CCK 33 into the volunteers, as we have shown that CCK 33 like immunoreactivity represents one of the important circulating molecular forms in humans, whereas CCK 8 was almost absent. 19 Given that the octapeptide of CCK is almost absent in human plasma it is probable that the human studies on CCK 8 and satiety examined a pharmacological effect rather than the physiological effect of CCK that we investigated using CCK 33.
Methods
Eight healthy obese women (age 41 (3) years, body mass index of 39 (2) kg/m2) and 10 age and sex matched healthy lean women (age 41 (2) years with a body mass index of 22 (3) kg/m2) were studied. Informed consent was obtained from all subjects. The investigations were approved by the local human ethics committee.
After an overnight fast the volunteers came to the laboratory at 0800. Saline or highly purified CCK 33 (1 IDU/kg ideal weight height, Karolinska Institute, Stockholm, Sweden) was infused through an intravenous catheter for 165 minutes, in random order and double blinded. The subjects actual weight was used as the ideal weight in the lean subjects and for obese subjects their height in cm was subtracted by 100 because it was known from previous experiments that this resulted in comparable plasma concentra tions. 16 The infusion was started at 0900. The two studies were separated from each other by at least one week. The subjects were investi gated on days irrespective of their time in the menstrual cycle. Sixty minutes after the start of the saline or CCK infusion, a banana 'shake* consisting of 100 g of banana slices, supple mented with 300 ml of water and mixed (132 kcal), was served and consumed within three minutes. Fifteen minutes later, at t=75 minutes a solid meal of slices of bananas in abundancy, containing 1 g/100 g of protein, 0 g/100 g of fat, and 32 g/100 g of carbohydrate was served and the meal was weighed before and afterwards to determine the exact amount of food consumed.
Banana slices were chosen because most people like them and they have only minimal CCK stimulating potency as was shown in our previous study without a preload. 16 Otherwise, if the preload or meal had Time (min)
Figure 1: (A) Desire to eat3 (B) hunger, (C) fullness, and (D) prospective feeding intentio?is during saline or cholecystokinin infusions from t= 0 until t= 165 minutes in 18 healthy women. After 60 minutes a banana 1 shake1 (preload-P) was consumed and 15 minutes later a meal

Figure 3: Plasma C C K concentrations during saline (open symbols) or C C K infusion (closed symbols) in (A) lean or (B) obese women. After 60 minutes a banana (shakeJ (preload~P) was consumed and 15 minutes later a meal Basal concentrations were comparable in lean and obese ■women as were the plasma concentrations during C C K infusion.
(AUC) before and after the meal followed by Wilcoxon matched pairs, signed rank test. Food intake and plasma CCK concentrations were compared using Wilcoxon's matched pairs signed rank test. Differences between lean and obese subjects were analysed using the Mann-Whitney U test.
Results
During CCK infusion food intake (282 (29) g) was significantly less for the 18 women than during saline infusion (346 (31) g, p<0*05). Subjective criteria, like desire to eat, hunger feelings, and prospective feeding intentions tended to be less during CCK infusions (Fig 1) , but the differences did not reach statis tical significance (p<0*06 for the AUC before and p=0*09 for the AUC after the meal for desire to eat and p=0*08 for the AUC after the meal for hunger feelings), There was also a significant satiating effect of CCK after the meal according to the food selection lists p<0-05 (Fig 2) . Analysing the protein, fatty, and carbohydrate items separately, this satiating effect of CCK was -specific for the fatty items, but not for the protein and carbohydrate rich items.
During CCK infusion in the lean women food intake (295 (45)) was also less than during saline (358 (43) g) but this difference just failed to reach significance (p = 0 '06). Also in the obese women CCK infusion induced a feeding depression from 331 (49) g during saline to 265 (36) g during CCK infusion (NS). There were also no differences found between lean and obese women with regard to subjective hunger feelings apart from a signifi cantly lower postprandial desire for fatty items in lean women during CCK (p<0*05) whereas there was no difference in obese women between saline and CCK.
Basal plasma CCK concentrations were not significantly different before the saline (2*7 (0'2) pM) and CCK infusion (2*6 (0*1) pM) and not significantly different in lean (2-9 (0*3) pM) and obese subjects (2*5 (02) pM).
Infusion of saline failed to significantly affect basal CCK concentrations in both lean and obese volunteers (Fig 3) . Infusion of CCK resulted in significant increases of plasma CCK concentrations to values fluctuating around 12 pM in both lean and obese subjects (Fig 3) . To stop the CCK infusion resulted in rapidly declining plasma CCK concentrations, which reached basal values within 30 minutes.
One of the lean subjects experienced a headache during both the saline and CCK experiment and another lean subject developed diarrhoea during the CCK experiment. There were no other adverse effects. In the lean subjects the duration of the meal was signifi cantly shorter with CCK (5*3 (0*88) min) than with saline (7*8 (1*43) min, p<0-05) whereas in obese subjects the duration of the meal with CCK (7*25 (1) min) and saline (7-5 (0*71) min) was comparable.
The appreciation of the meal was com parable between the saline and CCK experi ment (60 (5) v 64 (6) mm) and there was no nausea in lean and obese subjects.
D iscussion
This study shows for the first time that exogenously given CCK 33, resulting in plasma CCK concentrations seen after a mixed meal,23 significantly diminishes the size of a carbohydrate meal and increases postmeal satiety in humans. There were no clear differ ences in these satiating effects of CCK between the lean and obese subgroups.
Using the same CCK assay Fried et al found in healthy volunteers a CCK increase from 2-6 (0 • 4) pM to a maximum of 13 (4) pM after the ingestion of a mixed meal consisting of 60 g boiled chicken breast, 40 g of boiled chicken liver, one slice (28 g) of white bread spread with 15 g of margarine, 50 g of ice cream, and 250 ml of lemonade (0-4 M glucose flavoured with lemon concentrate). 24 This study differs from various other studies in several respects. Firstly, a solid meal contained almost exclusively carbohydrate without recorded CCK stimulation was ingested; secondly, infusion of CCK resulted in physiological plasma CCK concentrations, and thirdly, CCK 33 in contrast with CCK 8 was infused. In the studies on humans by Pi-Sunyer,3 Kissileff,4 Stacher,10 and Shaw11 where CCK 8 induced feeding depression, CCK plasma concentrations were not determined and it is probable that supraphysiological, pharmacological plasma con centrations were achieved. Pi-Sunyer and Kissileff infused 4 ng/kg/min of CCK 8, which is equivalent to about 3-6 pmol/kg/min of CCK 8. 25 CCK infusion induced a selective reduction of preference for fatty foods. This has also been shown for endogenous CCK26 and it is possible that the suppression of a fatty meal by CCK would be stronger than the suppression of the carbohydrate meal in our experiment. We are* however* still a long way from using CCK therapeutically as a treatment option for obesity. Unfortunately* CCK has to be given parenterally and has a very short half life in the circulation* making longterm administration difficult. Thus oral or nasal preparations with prolonged action have to be developed or a diet* which powerfully induces endogenous CCK release with a minimum of caloric load* has to be constituted. Another important problem is the lack of studies that show weight reduction during longterm administra tion.8 913 The meal frequency in rats is increased to compensate for the reduction in meal size5 7 and tolerance for CCK with repeated or continuous infusion supervenes in rats.6 27 It may be possible that CCK has to be combined with other satiation signals to induce weight reduction.
In conclusion* this study has shown that infusion of CCK 33 leading to plasma concen trations comparable with those after a meal decreases food intake in humans and that this effect is not different for lean and obese subjects.
